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Edited by Phyllis HansonAriadne-1 (Ari-1) is an E3 ubiquitin-ligase essential for
neuronal development, but whose neuronal substrates are yet to
be identified. To search for putative Ari-1 substrates, we used an
in vivo ubiquitin biotinylation strategy coupled to quantitative
proteomics of Drosophila heads. We identified 16 candidates
that met the established criteria: a significant change of at least
twofold increase on ubiquitination, with at least two unique
peptides identified. Among those candidates, we identified
Comatose (Comt), the homologue of the N-ethylmaleimide
sensitive factor (NSF), which is involved in neurotransmitter
release. Using a pull-down approach that relies on the over-
expression and stringent isolation of a GFP-fused construct, we
validate Comt/NSF to be an ubiquitination substrate of Ari-1 in
fly neurons, resulting in the preferential monoubiquitination of
Comt/NSF. We tested the possible functional relevance of this
modification using Ari-1 loss-of-function mutants, which dis-
played a lower rate of spontaneous neurotransmitter release due
to failures at the presynaptic side. By contrast, evoked release in
Ari-1 mutants was enhanced compared with controls in a Ca2+-
dependent manner without modifications in the number of
active zones, indicating that the probability of release per syn-
apse is increased in these mutants. This phenotype distinction
between spontaneous and evoked release suggests that NSF
activity may discriminate between these two types of vesicle
fusion. Our results thus provide a mechanism to regulate NSF
activity in the synapse through Ari-1-dependent ubiquitination.
Neurotransmitter release is mediated by a set of protein–
protein interactions that include the N-ethylmaleimide sensi-
tive factor (NSF), soluble NSF attachment proteins (SNAPs),
and SNAP receptors (SNAREs) (1). These proteins assemble
into a tripartite complex in order to elicit synaptic vesicle
fusion, which is formed by one synaptic vesicle membrane
SNARE protein (v-SNARE), Synaptobrevin, and two plasma
membrane SNARE proteins (t-SNAREs), Syntaxin and the 25-
kDa synaptosome-associated protein (2). Following vesicle* For correspondence: Alberto Ferrús, aferrus@cajal.csic.es; Ugo Mayor, ugo.
mayor@ehu.eus.
Present address for Miguel Morales: Orion Pharmaceutical, Turku, Finland.
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BY license (http://creativecommons.org/licenses/by/4.0/).fusion, the tripartite SNARE complex disassembles by the
activities of NSF and SNAPs (3). Free t-SNAREs from the
plasma membrane can then participate in new priming re-
actions, while the v-SNAREs can be incorporated into recycled
synaptic vesicles (4). These interactions, also routinely used for
intracellular vesicle trafficking in all cell types, are conserved
across species, including Drosophila (5).
Deviations on the rate of neurotransmitter release are at the
origin of multiple neural diseases, including Parkinson’s dis-
ease (6). Under physiological conditions, the Leucine-rich
repeat Serine/Threonine-protein kinase 2 (LRRK2) phos-
phorylates NSF to enhance its ATPase activity, which facili-
tates the disassembly of the SNARE complex (7–9). However,
the most common Parkinson’s disease mutation in LRRK2
causes an excess of kinase activity (10) that interferes with the
vesicle recycling (11). Similarly, α-Synuclein, another Parkin-
son’s disease protein (12), alters neurotransmitter release by
preventing the v-SNARE vesicle-associated membrane protein
(VAMP)-2, also known as Synaptobrevin-2, from joining the
SNARE complex cycle (13). Correct neural functioning,
therefore, requires delicate regulation in vesicle trafficking.
This regulation can be achieved by posttranslational modifi-
cations, such as ubiquitination. In fact, ubiquitination of
certain proteins can affect their activity or life span (14, 15). At
the presynaptic side, for example, increased neurotransmitter
release correlates with decreased protein ubiquitination (16).
Similarly, acute pharmacological proteasomal inhibition causes
rapid strengthening of neurotransmission (17).
Ariadne 1 (Ari-1) is an E3 ubiquitin-ligase, first identified in
Drosophila (18), from a conserved gene family defined by two
C3HC4 Ring fingers separated by a C6HC in-Between-Rings
domain, the RBR motif (19). Ari-1 had been described to be
essential for neuronal development, and its mutants reported
to exhibit reduced eye rhabdomere surface and endoplasmic
reticulum, as well as aberrant axonal pathfinding (18). How-
ever, despite its importance, no neuronal substrates have been
reported so far. Only three Ari-1 substrates have been postu-
lated, either in cultured cells or in vitro (20–22), while three
Parkin substrates were reported to interact with Ari-1 in COS-
1 cells (23). For this reason, with the aim to identify neuronal
Ari-1 substrates, we took advantage of two methodologiesJ. Biol. Chem. (2021) 296 100408 1
Biochemistry and Molecular Biology. This is an open access article under the CC
Ubiquitinated synaptic NSFdeveloped by our lab (24). The first one, the bioUb strategy,
allows the identification of hundreds of ubiquitinated proteins
from neuronal tissues (25, 26). The system relies on the
overexpression of a tagged ubiquitin that bears a 16 amino acid
long biotinylatable peptide (25, 27), which can be biotinylated
by the Escherichia coli biotin holoenzyme synthetase enzyme
(BirA) in neurons in vivo (25, 26). Remarkably, this approach
can be efficiently applied to identify neuronal E3 ligase sub-
strates (28, 29). The second methodology, in contrast, favors
the isolation of GFP-tagged proteins under denaturing con-
ditions to further characterize their ubiquitination pattern
under the presence or absence of an E3 ligase (30, 31).
Here we have combined the bioUb strategy with the over-
expression of Ari-1 and identified 16 putative neuronal sub-
strates of Ari-1. Among those, we focused on Comatose (Comt),
the fly NSF orthologue (32), due to its relevance in normal and
pathological function at the synapse. By the isolation of GFP-
tagged Comt from Drosophila photoreceptor neurons over-
expressing Ari-1, we confirmed Comt/NSF as an Ari-1 ubiquitin
substrate and showed that it is mostly monoubiquitinated.
Furthermore, we reported that Ari-1 loss-of-function mutants
displayed lower rate of spontaneous neurotransmitter release,
but enhanced evoked release, due to failures at the presynaptic
side. These defects in the mutants are compatible with a dereg-
ulation of Com/NSF activity. Altogether, our data show that Ari-
1 regulates neurotransmitter release by controlling Comt/NSF
activity through ubiquitination.
Results
Generation of flies for the identification of neuronal Ari-1
substrates
We generated GMR-Gal4, UAS-(bioUb)6-BirA/CyO; UAS-
ari-1/TM6 flies (hereinafter ari-1OE flies, from Ari-1 over-
expression) in order to screen, in an unbiased manner, for
putative substrates of the E3 ligase Ari-1. These flies over-
express in photoreceptor neurons (using the GMR-Gal4
driver) both an untagged version of Ari-1 protein (Fig. 1A) and
the (bioUb)6-BirA construct (Fig. 1B), which is the one that
provides the biotinylatable ubiquitins and the BirA enzyme to
the system. The rationale for using GMR-Gal4 is that it has
been shown to be a suitable driver for ubiquitin proteomics
experiments from mature neurons, in comparison with other
neuronal drivers tested (26). Flies only overexpressing the
(bioUb)6-BirA construct in photoreceptor neurons were used
as control. Overall, expression levels of biotinylated ubiquitin
were similar in both genotypes, as indicated by a western blot
performed with biotin antibody using whole head extracts (see
input fraction of Fig. 1C). Similarly, the amount of ubiquiti-
nated material eluted from biotin pull-downs on both fly lines
was also similar (see elution fraction of Fig. 1C).
Higher levels of Ari-1 enzyme in ari-1OE flies should result
in an enhanced ubiquitination of Ari-1 substrates relative to
control flies. Therefore, quantitative proteomic experiments
were carried out, following a previously described workflow
(28, 29), to decipher the ubiquitinated proteome from both
ari-1OE and control flies and, hence, detect those proteins2 J. Biol. Chem. (2021) 296 100408whose ubiquitination is regulated by Ari-1. In brief, we
collected 500 mg of heads of each fly genotype and subjected
triplicate samples to biotin pulldown and liquid chromatog-
raphy with tandem mass spectrometry (LC-MS/MS) analysis.
This allowed us to isolate, detect, and quantify ubiquitinated
proteins present in fly photoreceptor neurons expressing
physiological (control samples) and high (ari-1OE samples)
levels of Ari-1 (Fig. 1D). Only those proteins with at least a
twofold enrichment, determined with a p-value < 0.05, in ari-
1OE samples were considered as putative Ari-1 substrates
(Fig. 2A).
Identification of Ari-1 putative substrates by mass
spectrometry
Biotin pull-downs were performed on three biological rep-
licates for each condition. Identified ubiquitinated proteins
were highly reproducible across the three replicate samples of
each condition and also between both conditions (Fig. 2B).
Protein abundance was determined using label-free quantifi-
cation (LFQ) intensities (33), which also displayed a high
correlation across samples (Pearson correlation ≥ 0.96). For
statistical analysis, missing LFQ values were imputed with low
random values from a normal distribution, meant to simulate
expression levels below the detection limit. It should be noted
that proteins with too many imputed LFQ values were dis-
carded from the Ari-1 putative substrate list. Only proteins
with LFQ values in at least the three replicas of one of the
conditions, either ari-1OE or control, or in at least two replicas
of both conditions, are labeled in Figure 3.
Ari-1 protein was found significantly enriched (p =
0.0000176) in ari-1OE samples relative to control flies (Ari-1,
ari-1OE/control LFQ ratio of 26.1) (Fig. 3). By contrast, and in
agreement with western blotting results (Fig. 1C), ubiquitin
levels were similar in both conditions (Ub, ari-1OE/control
LFQ ratio of 0.73) (Fig. 3). The relative abundance of the
majority of proteins quantified did not change significantly
either; this included Avidin (AVD) and proteins known to be
endogenously conjugated with biotin (ACC: acetyl-CoA
carboxylase, PCB: pyruvate carboxylase) (25, 34), which serve
as internal controls to determine the correct processing of the
biotin pull-downs (Fig. 3, marked in blue).
Out of the 1452 proteins quantified (see control versus ari-
1OE Venn diagram in Fig. 2B, and Table S1), 22 proteins were
found significantly enriched (p-value < 0.05) by at least
twofold (log2 fold change >1) in ari-1
OE
flies relative to control
flies (Fig. 3, marked in green), including the Ari-1 E3 ligase
itself. Two proteins, Mdg3/ORF and Gag, correspond to
products encoded by genes within a transposable element,
whereas another two, Calx and MoxGM95, were only identi-
fied with one unique peptide. Additionally, Mccc1 had been
classified as background in previous biotin pull-down experi-
ments (26), as it uses biotin as cofactor. After excluding these
proteins, the final list of putative Ari-1 substrates contained 16
proteins (Table 1). Four of these putative Ari-1 substrates are
still uncharacterized Drosophila proteins (CG32486, CG32687,
CG4629, and CG6424), but the remaining ones are involved in
different metabolic processes (CG15117, GstO3, Lsp1β,
Figure 1. Generation of bioari flies. A, schematic representation of the domain structure of Drosophila Ari-1 E3 ligase according to Uniprot (ID: Q94981). Ari-
1 belongs to the RING between RING E3 ligase family, and as such, it is characterized by the presence of two RING domains (RING1 or R1 from residue
133–183 and RING2 or R2 from residue 291–322), which are separated by a conserved sequence called the in-between RING domain (IBR, from residue
203–264). ari-1OE flies overexpress an untagged version of Ari-1 in the photoreceptor cells under the control of the GMR-Gal4 driver. B, schematic repre-
sentation of the (bioUb)6-BirA precursor (25). It is composed of six copies of ubiquitin, which had been N terminus modified with a short biotinylatable
peptide (MGLNDIFEAQKIEWHEGSGSG). The biotin holoenzyme synthetase (BirA) is found at the C terminus. This construct is digested by endogenous
deubiquitinating enzymes, allowing the biotinylation of each ubiquitin molecule by BirA in vivo. Control and ari-1OE flies overexpress this precursor in the
photoreceptor cells under the control of the GMR-Gal4 driver. C, expression of the biotinylated ubiquitin is similar between ari-1OE and control (C) flies. Anti-
biotin western blot performed on whole lysates (inputs), as well as on the fractions coming from biotin pulldowns, where the ubiquitinated material is
enriched (elutions), is shown. The abundant pyruvate carboxylase (130 kDa), which is biotinylated endogenously, is highlighted with an arrowhead. D,
workflow for the identification of Drosophila Ari-1 substrates. In total, 500 mg of heads from ari-1OE and control flies was subjected to biotin pull-downs and
mass spectrometry analysis. MS data were analyzed by MaxQuant and Perseus softwares.
Ubiquitinated synaptic NSFOscillin, and PPO1), translation (EIFA), phototransduction
(Rh4 and Rh6), ATP-hydrolysis coupled transmembrane
transport (Vha 44 and Vha 68-1), and protein degradation
(Prosα7). The putative Ari-1 substrate identified with the
highest significance (p = 0.0000168) was Comt, a protein
known to be involved in neurotransmitter release. The human
orthologue of Comt, termed NSF (32), is known to regulate the
disassembly of the SNARE complexes once neurotransmitter
has been released (4).
The proteomics approach we applied does not particularly
enrich for ubiquitination sites, nevertheless we did also identify
150 peptides containing the characteristic GlyGly remnant of
ubiquitin. That is, the last two Glycines of ubiquitins that are
left covalently attached to the substrates after trypsin digestion
of the proteins (35). Of those, 64 GlyGly sites had been pre-
viously reported (26, 28, 29), but to our knowledge, 86 are
novel ubiquitination sites not described until now inDrosophila (Table S1). Among the sites identified, we did also
detect GlyGly remnants on the seven internal lysines of
ubiquitin, which indicates that all ubiquitin type chains are
present in fly neurons. The abundance of all ubiquitin chain
types was comparable in control and Ari-1 overexpressing flies
(Table S1), suggesting that high levels of Ari-1 do not alter the
overall landscape of the ubiquitin linkages in flies, neither
directly nor indirectly by affecting other ligases.
Comt is ubiquitinated by Ari-1 in Drosophila neurons in vivo
Having identified Comt as a putative substrate of Ari-1 by
mass spectrometry analysis, we decided to validate this result
biochemically. To that end, we combined flies that overex-
pressed a GFP-tagged version of Comt with the control and
ari-1OE fly lines previously used for the identification of pu-
tative Ari-1 substrates. The first combination gave rise to flies
that overexpress the (bioUb)6-BirA construct (Fig. 1B) togetherJ. Biol. Chem. (2021) 296 100408 3
Figure 2. Mass spectrometry data analysis. A, workflow for selection of Ari-1 putative substrates. After removing contaminants, missing LFQ values were
imputed and statistical significance determined by two-tailed Student’s t test. Proteins with twofold enrichment in ari-1OE samples relative to control were
considered as putative Ari-1 substrates. These proteins were further filtered according to the number of peptides and the imputed values in order to obtain
a list of high-confidence putative substrates. B, overlap between the MS-identified proteins from ari-1OE and control samples. Venn diagrams displaying the
overlap between the three ari-1OE and control replicas, as well as between the two conditions are shown.
Ubiquitinated synaptic NSFwith GFP-tagged Comt, termed comt flies (Fig. 4A). The
offspring of the second cross (the ari-1OE/comt flies) express
the Ari-1 E3 ligase (Fig. 1A), in addition to GFP-tagged Comt
and the (bioUb)6-BirA construct (Fig. 4A). We then performed
GFP-pull-down assays (30) using protein extracts from comt
and ari-1OE/comt flies, in order to isolate GFP-tagged Comt
and compare its ubiquitination levels in the presence of
physiological (comt) or high levels of Ari-1 (ari-1OE/comt)
in vivo. After pull-downs, which were performed in triplicate,
ubiquitinated and nonmodified fractions of Comt were
monitored using anti-biotin and anti-GFP antibodies, respec-
tively. We found a reduction of biotin and GFP signal in whole
extracts of ari-1OE/comt flies (Fig. S1A, input and Fig. S1B),
which led to a reduction in the amount of eluted GFP-Comt
protein from Ari-1 overexpressing flies compared with comt
flies (Fig. S1A, elution original WB). This can be explained by a
Gal4 dose effect, as the same dose of Gal4 protein is driving the
expression of two and three UAS constructs in comt and ari-
1OE/comt flies, respectively (Fig. 4A). In fact, a reduced
expression of the (bioUb)6-BirA construct, measured with anti-
BirA antibody, was also observed in ari-1OE/comt flies
compared with comt flies (Figs. S1 A and B). However, when
comparable levels of eluted GFP-tagged Comt from each ge-
notype were run on a gel, Comt was found highly ubiquiti-
nated in the presence of Ari-1 (Figs. 4B and S1A, normalized4 J. Biol. Chem. (2021) 296 100408WB). Interestingly, Ari-1 was found to preferentially enhance
the monoubiquitination of Comt. It should be noted that
monoubiquitination is a type of modification classically linked
to the endocytosis of cell surface receptors (36, 37).
NSF is ubiquitinated by ARIH1 in HEK293 cells
Once confirmed that Comt is an Ari-1 substrates in flies, we
aimed to test whether its human orthologue, NSF, is also
ubiquitinated by the human Ari-1 E3 ligase orthologue,
ARIH1. For that purpose, we generated a GFP-tagged version
of NSF that was transfected in HEK293 cells, together with
FLAG-tagged versions of either wild-type ARIH1 or catalyti-
cally inactive ARIH1 (Fig. 5A). The latter was generated by
mutating its active site Cysteine at position 357 to a Serine
(C357S), an amino acid that is able to bind ubiquitin but un-
able to transfer it to the substrates, as ubiquitin remains
attached to the Serine through an oxyester bond (30, 38). In
order to improve the detection of ubiquitin signal, cells were
further transfected with FLAG-tagged ubiquitin (Fig. 5A). Cell
extracts were subjected to GFP pulldown assay (30) and the
ubiquitinated fraction of GFP-NSF analyzed by western blot.
As expected, a significant reduction of the ubiquitinated levels
of NSF was observed in the presence of the catalytically
inactive ARIH1, confirming that NSF is also a substrate of
human ARIH1 (Fig. 5B). Interestingly, like its fly counterpart,
Figure 3. Putative Ari-1 substrates. Volcano plot showing differentially ubiquitinated proteins between ari-1OE and control flies. Abundance of each
individual protein was determined by the sum of LFQ intensities of the three replicas performed. LFQ ari-1OE/Control ratios in the x-axis (in log2 scale) and
the t test p-values in the y-axis (in −log10 scale) are displayed. The horizontal gray lane indicates the statistical significance (p-value < 0.05), while vertical
gray lanes represent a twofold increase (log2 LFQ ari-1
OE/Control = 1) or a twofold decrease (log2 LFQ ari-1
OE/Control = −1), of the ubiquitination levels.
Endogenously ubiquitinated proteins (ACC and PCB), Avidin (AVD), as well as ubiquitin (Ub) are shown in blue. Proteins whose ubiquitination increases or
reduces at least twofold upon Ari-1 overexpression are shown in green and red, respectively. Ari-1 is shown in purple.
Ubiquitinated synaptic NSFhuman NSF was also found to be preferentially mono-
ubiquitinated in HEK293 cells. Altogether, these results
confirmed that Comt/NSF is an in vivo target of Ari-1/ARIH1
E3 ubiquitin ligase, in both Drosophila and humans.
Ari-1 mutations alter spontaneous and evoked
neurotransmitter release
Comt/NSF is a well-known component of the SNARE
complex (3). SNARE complex formation bridges the vesicles
and plasma membranes, mediating neurotransmitter release at
synapses. As currently thought, NSF-SNAPs disassemble the
SNARE complex by an ATP hydrolysis dependent process,
allowing to recycle and to reuse SNARE components for a
following round of vesicle fusion (5, 39). Consequently, we
reasoned that Ari-1 might play a role in neurotransmission
also. In order to test this hypothesis, we first analyzed spon-
taneous neurotransmitter release under two electrode voltage
clamp conditions (TEVC). The frequency of spontaneous
miniature events in neuromuscular junctions (NMJs) of ari
mutant larvae was reduced over 50% relative to controls
(Fig. 6, A and B) suggesting a presynaptic modification in
mutant terminals. The mean of miniature excitatory junctional
current (mEJC) frequencies in controls were 2.19 ± 0.26 Hz in
normal larvae, 2.46 ± 0.29 Hz in the male ari2 mutant covered
by the duplication Dp(1;3)JC153 (ari2; Dp), and 2.78 ± 0.26 Hzfor the female siblings (ari2/+ ♀). These genotypes constitute
different forms of controls. By contrast, mEJCs in male mutant
larvae were 1.02 ± 0.12 Hz for ari2, 1.20 ± 0.38 Hz for ari3, and
0.92 ± 0.12 Hz for ari4. The reduced mEJC frequency of all ari
mutant alleles indicates a relatively low rate of spontaneous
synaptic vesicle fusion, which could arise from either a
decreased number of release sites or a reduced probability of
spontaneous vesicle fusion.
To further analyze spontaneous release, we compared the
amplitude and time course of spontaneous mEJCs in ari2 ♂
versus ari2/+ ♀ larvae (Fig. 6C). The mean ari2 mEJC peak
amplitude (0.73 ± 0.007 nA, n = 7 cells) was not significantly
different from that of ari2/+ controls (0.75 ± 0.02 nA, n = 7).
Cumulative frequency distribution of mEJC amplitudes (Fig. 6C)
also revealed not significant differences between ari2 ♂ and ari2/
+ ♀ larvae. Further, both genotypes showed a very similar mEJC
time course (Fig. 6C, inset). The fact that mEJC amplitude and
time course remain the same in ari2 indicates that postsynaptic
glutamate receptor properties and receptor density per active site
are not altered and further reinforce the hypothesis that the
primary mutant defect is at the presynaptic site.
We also noticed a conspicuous enlargement of evoked release
in ari2 mutants. Postsynaptic evoked synaptic currents (EJC) in
ari2 males were larger than those of the heterozygous female
controls (Fig. 6D). To characterize in detail these effects, EJCsJ. Biol. Chem. (2021) 296 100408 5
Table 1
High confidence putative Ari-1 substrates
Namea MW (kDa) FC p-value Unique peptides Biological process Orthologueb
PPO1 79 101.70 3.03E-04 7 Dopamine metabolic process -
Vha44 92 7.46 2.81E-04 3 Proton transmembrane transport ATP6V1C1
CG15117 71 5.69 3.05E-02 2 Carbohydrate metabolic process GUSB
CG6424 88 4.35 2.63E-02 6 - FAM13A
Oscillin 29 3.66 1.09E-04 3 Glucosamine catabolic process GNPDA2
Rh6 41 3.62 1.63E-03 2 Phototransduction OPN4
CG32486 45 2.88 3.72E-03 6 - CYHR1
Lsp1β 95 2.82 1.95E-02 2 - -
GstO3 27 2.61 1.62E-03 2 Glutathione metabolic process GSTO1
CG4629 63 2.52 3.82E-03 11 Protein phosphorylation NIM1K
Rh4 42 2.47 6.32E-03 6 Phototransduction OPN4
Comt 82 2.41 1.68E-05 26 SNARE complex disassembly NSF
EIF-1A 17 2.28 2.28E-03 4 Translation EIF1AY
Prosα7 27 2.27 2.45E-03 8 Proteasomal catabolic process PSMA3
CG32687 41 2.27 1.95E-02 3 - LRRC58
Vha68-1 68 2.05 4.29E-03 16 Proton transmembrane transport ATP6V1A
Fly protein names. sizes (MW), unique peptides, and the biological process they are involved in are reported. ari-1OE/control fold changes (FC) and its statistical significance
(p-value) are also given. The complete data set, as well as all GlyGly peptides, is available as Supporting information in Table S1.
a Given according to Flybase nomenclature (https://flybase.org/).
b Humna orthologues with the best Flybase score are provided.
Figure 4. Validation of Comt as an Ari-1 substrate. A, workflow for the validation of Comt as Ari-1 substrate. comt flies express the (bioUb)6-BirA construct
(biotin-Ub; see Fig. 1B) and a GFP-tagged version of Comt (Comt-GFP) under the control of the neural photoreceptor expressed GMR-Gal4 driver. ari-1OE/
comt are comt flies that express, in addition, the Ari-1 E3 ligase. In total, 100 mg of head of each genotype was lysed and incubated with anti-GFP beads in
order to isolate GFP-tagged Comt. After stringent washes with 8 M Urea and 1% SDS, the ubiquitination levels of GFP-tagged Comt in both genotypes were
determined by western blot with anti-biotin antibody. Nonmodified GFP-tagged Comt was monitored with anti-GFP antibody. B, Comt-GFP is ubiquitinated
by Ari-1. Western blot performed on isolated GFP-tagged Comt in the presence of physiological (comt) or high levels of Ari-1 (ari-1OE/comt). Equal levels of
GFP-tagged Comt were loaded in order to have comparable ubiquitinated levels. Ubiquitinated fraction (red) was monitored with anti-biotin antibody, while
anti-GFP was used to detect the nonmodified fraction (green). Below, a quantification of both mono and polyubiquitinated forms of GFP-tagged Comt from
three independent pulldowns is shown. Semiquantification of dual-color western blots was performed with Image Lab software (Bio-Rad), ubiquitination
levels of GFP-tagged Comt (red) were normalized to the nonmodified fractions (green) and statistical significance determined by two-tailed Student’s t test.
In this graph ubiquitinated Comt levels in ari-1OE/comt flies were additionally normalized to the levels found in control flies (comt) for a clearer repre-
sentation; in comt flies ubiquitinated levels are, therefore, shown as 1 (dash horizontal line). *p-value = 0.0146.
Ubiquitinated synaptic NSF
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Figure 5. Validation of human NSF as an ARIH1 substrate. A, western
blot on HEK293 whole cell extracts. HEK293 cells were cotransfected with
FLAG-tagged ubiquitin, GFP-NSF, and either FLAG-tagged ARIH1WT (WT) or
the catalytically inactive ARIH1C 357S (CI) E3 ligase. GFP-NSF levels were
detected with anti-GFP antibody. FLAG-ubiquitin and FLAG-ARIH1 levels
(arrowhead in the upper panel) were detected with anti-FLAG antibody.
Tubulin was used as loading control. B, GFP-NSF is ubiquitinated by ARIH1.
Western blot performed on isolated GFP-tagged NSF in the presence of
wild-type ARIH1 (WT) or a catalytically inactive ARIH1 (CI). Ubiquitinated
fraction (red) was monitored with anti-FLAG antibody, while anti-GFP was
used to detect the nonmodified fraction (green). Below, a quantification of
GFP-tagged NSF from three independent pulldowns is shown. Semi-
quantification of dual-color western blots was performed with Image Lab
software (Bio-Rad) and statistical significance determined by two-tailed
Student’s t test. *p-value = 0.0177.
Ubiquitinated synaptic NSFamplitudes were analyzed at various extracellular Ca2+ concen-
trations (from 0.3 to 1.2 mM) by stimulating the fibers at 0.2 Hz.
In all Ca2+ concentrations tested, ari2 ♂ EJC amplitudes were
larger than those of the female controls, although differences
reached statistical significance at 1.2 and 0.90 mMonly (Fig. 6E).
Thus, in the presence of 1.2 mM extracellular Ca2+, the mean
peak EJC amplitude for ari2 ♂ was 124.61 ± 9.72 nA (n = 6)
compared with 77.20 ± 5.33 nA, (n = 6) for ari2/+ females.
Similar differences were found at an extracellular Ca2+ concen-
tration of 0.90mM (ari2♂: 73.3 ± 9.5 versus 43.2 ± 4.3 nA in ari2/
+ ♀) while at lower concentrations: 0.6 mM (ari2 ♂: 19.2 ± 6.8
versus 12.2 ± 1.6 nA in ari2/+♀), 0.45mM (ari2♂: 5.2 ± 1.7 versus
2.9 ± 0.5 nA inari2/+♀), and 0.3mM(ari2♂: 1.0 ± 0.2 versus 0.5±
0.0 nA in ari2/+ ♀) differences were not statically significant.
Short-term synaptic depression observed during long high-
frequency stimulation is associated with the slower replen-
ishment of the readily releasable pool (RRP) (40), reflecting the
number of vesicles docked and ready to be released. Accord-
ingly, rapid stimulation depletes the RRP and the subsequent
responses rely on the replenishment of the RRP. In order to
examine the possible effects of ari over the whole synapticrefilling process, we employed a 10 Hz stimulation protocol to
monitor synaptic vesicle replenishment (Fig. 6F). The average
results of six different experiments did not show any difference
between ari2 ♂ and its sibling female controls.
A larger EJC can be explained by a relative large number of
synaptic release sites. To discard this possibility, the number of
synaptic contacts was analyzed and compared (Fig. 7, A and B).
We found that the total number of synaptic contacts onto
muscle fibers 6/7 (abdominal segment 3) in ari2 ♂ (82.55 ±
4.37, n = 20) was not significantly modified with respect to
female controls ari2/+ ♀ (79.72 ± 3.62, n = 22). Actually, no
obvious morphological difference in NMJs between mutant
and control larvae could be found.
The fact that evoked synaptic release is increased in ari2 ♂
while exhibiting a similar number of synaptic contacts would
argue for an upregulation of quantal release per synapse. To
explore this possibility, we performed a failure test analysis (41),
by means of focal recordings of single boutons (type Is) (42)
while simultaneously recording the muscular depolarization
(EJP: Excitatory Junctional Potential) from the corresponding
muscle fiber (Fig. 7, C and D). The Ca2+ concentration in the
bath and inside the pipette was the same (0.6 mM nominal).
The rate of synaptic failures was set to yield about a 50% failure
rate in control animals by adjusting the stimulation potential.
Under this condition 52.1 ± 4.2% (n = 8 recording sites from
eight different animals) of stimuli failed to elicit neurotrans-
mitter release in ari2/+ ♀ animals, whereas in ari2 ♂ mutants,
transmitter release failed only in 30.1 ± 4.9% (n = 8) of the cases
(Fig. 7D). This difference is statistically significant (p = 0.0054)
and indicates that mutant boutons release more neurotrans-
mitter in response to nerve stimulation.
We considered two possible mechanisms to explain this
enhancement: (1) mutant boutons contain larger amounts of
transmitter release machinery and therefore more release sites,
and (2) the probability of vesicle fusion in response to calcium
at each release site is increased in the mutant. To distinguish
between these two alternatives, we examined transmitter
release from single varicosities at very high calcium concen-
trations. The rationale behind is that, at a calcium concen-
tration that saturates the release machinery, most release sites
would be recruited during nerve stimulation, and the ampli-
tude of the synaptic response would mainly be governed by the
number of release sites.
For these experiments, the bathing solution and the focal
pipette contained 0 and 20 mM calcium, respectively (Fig. 7E).
The calcium-containing pipette was placed over single type Is
boutons, and the EJP was recorded with an intracellular elec-
trode (Vm in the range of –35 mV to –40 mV, Fig. 7E). Each
EJP amplitude data was the average of 20 consecutive re-
sponses from the same bouton, elicited at 0.1 Hz intervals,
provided that no trend toward synaptic response decrement
was observed. The amplitudes of the intracellular recorded
EJPs were 4.1 ± 0.3 (n = 6 recording sites from six different
animals) and 4.2 ± 0.5 (n = 5) in control and mutant animals,
respectively (Fig. 7F); the difference not being statistically
significant. These results indicate that, under conditions of
elevated probabilities of release, mutant terminals do notJ. Biol. Chem. (2021) 296 100408 7
Figure 6. Synaptic release is affected in ari-1 mutants. A, mEJC frequency in ari-1 mutants is reduced. Representative traces from a spontaneous mEJCs
recording. Events were captured under TEVC (Vh = –80 mV) from larval muscle 6 fibers in ari2 mutant male (top) and in heterozygous ari2/+ female siblings
(bottom). B, quantification of the effects over spontaneous release. mEJC frequency (mean ± SEM) was calculated from the following larvae strains; (wt),
ari2♂ covered by the duplication Dp(1;3)JC153 (ari2;Dp), heterozygous ari2 female siblings (ari2/+ ♀), ari2 ♂ and two additional ari alleles (ari3 and ari4), and
their respective heterozygous females. Student’s t test. Note the consistent reduction of mEJC frequency across all mutant genotypes with respect to the
sibling female controls. ari2 is a C150Y mutation in the first R motif of the RBR domain; ari3 is a C309Y mutation in the second R motif; and ari4 is a point
mutation that generates a STOP codon at amino acid 91. C, neither size nor mEJC time course is affected in ari2 animals. Cumulative probability curve of
mEJC amplitudes for ari2/+ ♀ (black) and ari2 ♂ (red) larvae (n = 7 larvae). Inset: average representative mEJC traces from ari2 ♂mutant superimposed to that
of ari2/+ ♀. Traces were scaled up to the maximum peak value. D, representative traces of evoked transmitter release recorded under TEVC (Vh = −80 mV), at
increasing extracellular Ca2+ concentrations (from 0.3 to 1.2 mM), recorded from sibling ari2/+ ♀ and ari2 ♂ larvae. E, quantification of Ca2+ dependence of
evoked release. Maximal EJC response was plotted versus the extracellular calcium concentration for ari2 ♂ compared with ari2/+ ♀ (n = 6 for all genotypes;
one-way ANOVA post hoc: Student’s t test). F, quantification of EJC trains in response to a 10 Hz stimulation. Peak size was normalized to their initial
response. Average of six different experiments from ari2 ♂ and ari2/+ ♀ larvae.
Ubiquitinated synaptic NSFrelease more transmitter than controls. We interpret this
result in the sense that the number of release sites per bouton
is not modified in the mutant and favor the hypothesis of a
regulatory mechanism that increases transmitter release
probability at physiological calcium concentration.
Ari-1 and comt mutants interact in vivo
In order to assay if the proposed interactionbetweenAri-1 and
Comtwould reflect in phenotypic changes at thewhole organism
level, we analyzed the thermo-sensitive paralysis and recovery of8 J. Biol. Chem. (2021) 296 100408the comt6 allele, a single amino acid substitution, P398S, in Comt
mutant background.To that end, we recombined comt6with ari2
andmonitored the paralysis at 37 C and recovery times at room
temperature of comt6/comt6 versus comt6 ari2/comt6 females
(Fig. 8). The data show that, although paralysis time was not
affected by the presence ofari2 in onedose, the recovery timewas
severely extended in comparison to comt6 alone. As control, the
comt6 ari2/FM7 or ari2/FM7 females did not paralyze at all.
Noticeably, the comt6 ari2/comt6 females during the recovery
time show uncoordinated movement of legs and some of them
Figure 7. Ari-1 mutants have low synaptic failure rate. A, synaptic density is not affected by ari2 mutation. Synaptic boutons were identified by
inmunostaining against the presynaptic protein CSP. Representative confocal images from ari2 ♂ mutant (top) and control (bottom) neuromuscular
junctions (muscle 6). Bar = 10 μm. B, the average number of synaptic boutons in larval motorneurons from ari2 ♂ compared with the sibling heterozygous
ari2/+ ♀ are not statistically different. C, ari2 ♂ mutants have fewer transmitter release failures. Top drawing: scheme of the recording. An extracellular focal
recording of the synaptic current (type Is) is done by the help of a patch pipette placed over the presynaptic terminal. Calcium was kept at the same
extracellular concentration (0.6 mm). The excitatory junction potential (EJP) was recorded from the muscle fiber. Bottom: representative traces of a
simultaneous focal and EJP recording. In red, an ari2 ♂ recording, superimposed to a female ari2/+ ♀ (black traces). Note how a single bouton failure
correlates with a normal EJP at the muscle fiber level, indicating that it represents a true failure to recruit the release sites under the focal recording pipette.
D, the mean average number of failures was smaller in the ari2 ♂ mutants (n = 8) when compared with the heterozygous ari2/+ ♀ (n = 8). Student’s t test. E,
in ari2 mutants, the release probability is higher in physiological calcium concentrations. Top drawing: scheme of the recording. Extracellular calcium was
kept at 0 mM nominal concentration to inhibit release, while the presynaptic bouton under the focal recording was kept at 20 mM to maximize release
probability. Bottom: representative average evoked EJPs recorded in muscle fiber 6 from ari2 ♂mutants (red) and control larvae ari2/+ ♀ (black). Each trace is
the average of 20 consecutive recordings at 0.1 Hz stimulation. To reduce calcium dilution inside the pipette, we employed a fresh pipette every time and
proceeded with the experiment as quickly as possible. F, average EJP amplitudes corresponding to data collected from ari2 ♂ mutants (n = 5) and ari2/+ ♀
controls (n = 6). The average size was not different when release probability was increased.
Ubiquitinated synaptic NSFrequired more than 1 h to reach the standup criterion (see
Experimental procedures). These flies, however, eventually
recover and exhibit normal movements including jump and
flight. This feature is compatible with the requirement of Ari-1
activity upon NSF in various aspects of the normal organism
biology beyond the regulation of neurotransmitter release. In thiscontext, the increase, rather than decrease, of the paralysis re-
covery time of the double-mutant flies may result from the
reduced ARI ligase activity, due to ari2 heterozygosity, upon
other synaptic target proteins (e.g., Vamp-7, among others,
Fig. 3). Alternatively, the disequilibrium between the ari2 effects
upon spontaneous versus evoked release (Figs. 5 and 6) and/or aJ. Biol. Chem. (2021) 296 100408 9
Figure 8. Genetic interaction between ari2 and comt6 mutants. Time to
reach full paralysis in a 37 C water bath of comt6/comt6 females is not
statically significant with respect to comt6 ari2/comt6 (mean 311 ± 31 versus
253 ± 22; p = 0.14). The recovery time shows a strong increase in the later
genotype, where three out of 13 individuals required more than 1 h to
reach the recovery criterion (not included). Eventually, all flies fully recov-
ered from temperature paralysis. On average, the mean recovery time was
of 893 ± 82 and 1693 ± 116, comt6/comt6 versus comt6 ari2/comt6, respec-
tively. These values are statistically different under the unpaired Student’s t
test; p < 0.0001. As control, comt6 ari2/FM7 females were tested in parallel
showing no paralysis during the whole time of the test.
Ubiquitinated synaptic NSFputative differential effect upon excitatory versus inhibitory
synapses could contribute to the phenotype change. These
speculations, however, will require focused studies in the future.
Discussion
We identified 16 novel putative substrates of Ari-1 in
Drosophila photoreceptor neurons in vivo by means of an
unbiased proteomic approach. Remarkably, despite Ari-1 be-
ing recently shown to regulate the positioning of the cell nu-
cleus in muscles via a direct interaction with Parkin (21), as
well as to interact with some Parkin substrates (21, 23), there is
no overlap between the substrates identified for Ari-1 and
those previously identified for Parkin in flies (28). Taken
together, the available data suggest that the 16 targets identi-
fied here are specifically regulated by Ari-1 in Drosophila
photoreceptor neurons and that this E3 ligase has a wide
functional repertoire.
We focused this study on Comt, an ATPase required for
the maintenance of the neurotransmitter release (32).
Ubiquitination of proteins involved in vesicle trafficking and
neurotransmitter release had been previously reported
(17, 25, 26, 43). Similarly, the importance of the ubiquiti-
nation machinery for the proper neuronal function has also
been demonstrated (14, 16, 44, 45). The alterations produced
on synaptic transmission by ubiquitination are typically
attributed to an acute control of synaptic protein turnover
(17, 46). However, many of these presynaptic proteins have
been reported to be mainly mono- or di-ubiquitinated (25,
26), a type of ubiquitin modification that is not usually
associated with protein degradation. In line with this, our
results showed that Comt/NSF is preferentially mono-
ubiquitinated by Ari-1/ARIH1, suggesting that Ari-1/ARIH1
could be regulating Comt/NSF activity, rather than its life
span or expression levels.10 J. Biol. Chem. (2021) 296 100408Ari-1 mutations result in abnormal synaptic function at the
larval stage, a result consistent with a regulatory function of
NSF. All mutant alleles examined exhibit a reduced frequency
of spontaneous synaptic release. In addition, ari-12 mutants
exhibit a large calcium-dependent evoked release. Analysis of
the mechanism for enhanced evoked release in ari-12 suggests
that the primary defect consists in an increased probability of
vesicle fusion in response to calcium entry in the presynaptic
side. First, by comparing the amplitude and time course of
spontaneously occurring postsynaptic events in mutant and
control animals, we ruled out the possibility of a postsynaptic
modification. Since no significant differences were found, we
concluded that the receptor field size and kinetic properties of
postsynaptic receptors are normal in the mutant.
The ari-1 functional defects could result from alterations of
synaptic transmission during development (47); therefore, we
quantified the number of synaptic contacts, assuming that
most release sites occur within varicosities (48). We did not
observe any significant difference between mutant and control.
Although this study does not include electron microscopy
quantification of synaptic vesicles, our confocal microscopy
and electrophysiology data point toward an upregulation of
release from single synapses.
The failure analysis from single varicosities represents direct
evidence that, at relatively low calcium concentrations, mutant
terminals release more quanta than controls in response to an
action potential. We further examined whether increased
quantal release could be explained on the basis of more release
sites being concentrated on mutant terminals. The focal re-
cordings using saturating calcium concentrations argue
against this possibility. When mutant terminals are exposed to
high calcium, in order to increase the likelihood that all active
zones within the bouton will release a quantum, EJP ampli-
tudes in the mutant are indistinguishable from that of controls.
These data suggest that the number of release sites in mutant
and control terminals is similar and favor the hypothesis that,
at physiological calcium concentrations, the probability of
vesicle fusion upon calcium entry is increased in the mutant.
We found that ari-1 mutants have opposite effects on
spontaneous and evoked release. Classically, the two modes of
vesicular release have been considered to represent a single
exocytotic process that functions at different rates depending
on the Ca2+ concentration. However, recent work challenges
this idea and supports the alternative model where sponta-
neous and evoked response might come from different vesicles
pools (49). Several experimental evidences indicate that both
forms of release may represent separate fusion pathways
(50–53). Employing a state-of-the-art optical imaging in larval
NMJ, it has been shown that evoked and spontaneous release
can be segregated across active zones. Thus, three types of
active zones could be defined: those that only release vesicles
in response to a rise of intracellular calcium (evoked release), a
second population that only participates in spontaneous
release, and a third small proportion (around 4%) that par-
ticipates in both evoked and spontaneous release. This result
advocates for a different molecular and spatial segregation of
both modes of release (52).
Ubiquitinated synaptic NSFDifferential content or activity of regulatory SNARE binding
proteins could discriminate between spontaneous and evoked
release. It has been shown that the presence of the Vamp-7
isoform could participate in this differential release. Vamp-7
preferentially labels vesicles unresponsive to stimulation, and
it colocalizes only partially with the endogenous synaptic
vesicle glycoprotein Sv2 and the vesicular glutamate trans-
porter Vglut1, suggesting that this vesicle pool does not sup-
port evoked transmitter release (51). Recently, it was shown
that the double knockout mouse for Synaptobrevin genes, syb1
and syb2, results in a total block of evoked release, while
spontaneous release was increased in both frequency and
quantal size without changes in the number of docked vesicles
at the active zone (53), confirming the idea that evoked and
spontaneous releases are differentially regulated. Interestingly,
Vamp-7 was found by MS to be less ubiquitinated when Ari-1
is overexpressed (Fig. 3), suggesting that Ari-1 mutants could
be favoring evoked release through NSF and reducing spon-
taneous release through Vamp7. Thus, Ari-1 could be acting as
a repressor and activator of evoked and spontaneous release,
respectively. All together, these results evidence a new layer of
complexity over the actual fine-tuning of synaptic trans-
mission. A physiological regulatory mechanism for both types
of release has been recently demonstrated for inhibitory syn-
apses at the trapezoid body, an important brain area in audi-
tory integration. In this nucleus, activation of metabotropic
glutamate receptor mGluR1 differentially modulates both
spontaneous and evoked release in both GABAergic and
Glycynergic synapses (54).
Early functional studies of NSF employing the fly thermo-
sensitive mutant allele comtts17, have reported a reversible
reduction of synaptic transmission. Consistent with a role of
NSF on SNARE dissociation, this inhibition parallels an in-
crease in the number of synaptic vesicles at the presynaptic
terminal (55–57). At this point, we can only speculate how
specifically Ari-1/ARIH1 regulates Comt/NSF activity within
the presynaptic terminal. Opposite to the role of NSF mutant
comst17, which impairs SNARE complex disassembly (55), a
change that enhances NSF functionality due to the lack of its
ubiquitination would favor the dissociation of the so-called
trans-SNARE complex. Further, this would build up the
number of SNARE complexes assembled per vesicle, thus
increasing the efficiency of fusion machinery in a Ca2+-
dependent manner. Consistent with this interpretation, it has
been shown that fast release of a synaptic vesicle requires at
least three SNARE complexes, whereas slower release may
occur with fewer complexes (58).
Interestingly, some of the additional putative substrates
identified are also related to synapse physiology and neuro-
transmitter release. PPO1 is an enzyme with L-DOPA mono-
oxygenase activity, hence, may be involved in the metabolism
of dopamine neurotransmitter (59). Similarly, GstO3 is
involved in glutathione metabolism (60), another type of
neurotransmitter (61). Vha44 and Vha68-1 are components of
the vacuolar proton-pump ATPase (62), whose mutations have
been reported to impair neurotransmitter release (63). Vha44
has also been described as an enhancer of Tau-inducedneurotoxicity (64), and CG15117, orthologue of human
GUSB, has been associated with neuropathological abnor-
malities (65). The long recovery time from paralysis observed
in comt6 ari2/comt6 females could result from the role of Ari-1
in the ubiquitination of these additional substrates, in addition
to the role of Comt in tissues other than the nervous system.
The data reported here may be relevant in the context of
Parkinson’s disease. It should be noted that most Parkinson’s-
related genes encode proteins involved in vesicle recycling and
neurotransmitter release at the synapse (66). Thus, the kinase
LRRK2 phosphorylates NSF to enhance its ATPase activity
upon the SNARE complex and facilitate its disassembly (7–9).
Pathological mutations in this protein, such as G2019S, cause
an excess of kinase activity (10) that interferes with vesicle
recycling (11). Deregulated synaptic aggregates of α-Synuclein
may target VAMP-2 hampering the formation of the SNARE
complex (13, 67). Parkin is a structural relative of Ari-1, based
on their common Cysteine rich C3HC4 motif (19), which is
also at the origin of some forms of Parkinson’s disease (68). All
these genes and their corresponding mechanisms of activity
sustain the scenario in which several types of Parkinson’s
disease seem to result from a defective activity of the synapse.
In this context, the role of Ari-1/ARIH1 emerges as a mech-
anism to regulate a key component of the SNARE complex,
Comt/NSF. Conceivably, Ari-1/ARIH1 may become a suitable
target for either diagnosis or pharmacological treatment of
Parkinson’s and related diseases.Experimental procedures
Fly strains and genetic procedures
The four ari-11–4 alleles have been previously described and
sequenced (18), and the protein sequence can be found in the
EMBL data bank under accession number #Q94981. The
insertional duplication Dp(1;3)JC153 (Dp for brevity) is
routinely used to cover the lethality of ari-1 and to demon-
strate that the mutant phenotype is due to the gene ari-1,
rather than to a putative second site mutation along the
chromosome. UAS-ari-1 flies, as well as flies overexpressing
the (bioUb)6-BirA construct in the Drosophila photoreceptor
neurons under the control of the GMR-GAL4 driver (GMR-
Gal4, UAS-(bioUb)6-BirA/CyO; TM2/TM6), had been previ-
ously described (22, 26). UAS-comt-GFP flies, used for the
overexpression of the Drosophila NSF1 protein, were obtained
from Dr R. Ordway (Penn State University).
UAS-ari-1 flies were mated to GMR-Gal4, UAS-(bioUb)6-
BirA/CyO; TM2/TM6 control flies to generate GMR-Gal4,
UAS-(bioUb)6-BirA/CyO; UAS-ari-1/TM6 flies (abbreviated
throughout the text as ari-1OE). Control and ari-1OE flies were
then mated to UAS-comt-GFP flies in order to generate
GMR-Gal4, UAS-(bioUb)6-BirA/CyO; UAS-comt-GFP/TM6
(abbreviated throughout the text as comt), and GMR-Gal4,
UAS-(bioUb)6-BirA/CyO; UAS-ari-1/UAS-comt-GFP flies
(abbreviated throughout the text as ari-1OE/comt), respec-
tively. Mixed-sex flies of 2–5 days old of each genotype (bioUb,
bioari, biocomt and bioari/comt) were frozen in liquid nitrogen
and their heads were collected using a pair of sieves with aJ. Biol. Chem. (2021) 296 100408 11
Ubiquitinated synaptic NSFnominal cutoff of 710 and 425 μm as previously described
(26, 29). Fly heads were then stored at –80 C until required.
All fly lines were grown at 25 C in 12 h light–dark cycles in
standard Drosophila medium.
Plasmids and cloning procedures
FLAG-taggedubiquitin (30) in pcDNA3.1 vectorwas generously
provided by Dr Jose Antonio Rodríguez Pérez (University of the
Basque Country-UPV/EHU, Spain). pFLAG-ARIH1WT plasmid,
overexpressing an N-terminally FLAG-tagged version of the wild-
type human ARIH1 protein, was a gift from Dong-Er Zhang
(Addgene plasmid # 17450; http://n2t.net/addgene:17450; RRID:
Addgene_17450). A catalytically inactive version of ARIH1 was
generated by site-directed mutagenesis of the active-site Cysteine
(C357) to a Serine (pFLAG-ARIH1C357S). The procedure was car-
ried out with the QuickChange Site-Directed mutagenesis kit
(Agilent Technologies), according to the manufacturer’s in-
structions. The primers used for the mutagenesis were the
following: 50-GACAGACCATGTGATTAGAACCACCATCCT
TCTCA-30 and 50-TGAGAAGGATGGTGGTTCTAATCA-
CATGGTCTGTC-30. Plasmid correct sequence was confirmed by
sequencing at NZYtech (Portugal).
N-terminally GFP-tagged NSF plasmid (pEGFP-NSF) was
generated by cloning NSF gene between KpnI and SmaI sites
of the pEGFP-C1 vector (Clontech). For that, human NSF was
amplified from pcDNA3-FLAG-NSF plasmid, a gift from Elisa
Greggio (Addgene plasmid # 74924; http://n2t.net/addgene:74
924; RRID: Addgene_74924), using the NSF-forward (50-
ACCGGTACCGCGGGCCGGAGCATGC-30) and the NSF-
reverse (50-ACCCCCGGGTCAATCAAAATCAAGGGGGC-
TAGC-30) primers. In-frame position of NSF relative to GFP
was confirmed by sequencing at NZYtech.
Cell culture and transfection
Human Embryonic Kidney cells (HEK293T) were cultured
under standard conditions (37 C, 5% CO2) in Dulbecco’s modi-
fied Eagle medium/nutrient mixture F-12 (DMEM/F-12) with
GlutaMAX (Gibco), supplemented with 10% fetal bovine serum
(Gibco), 100 U/ml of penicillin (Gibco) and 100 μg/ml of strep-
tomycin (Gibco).About 6×105 cellswere seeded in six-well plates
for GFP pull-down assays. Next day, cells were cotransfected with
1 μg of pcDNA3.1-FLAG-ubiquitin, 1 μg of pEGFP-NSF, and
either 1 μg of pFLAG-ARIH1WT or pFLAG-ARIH1C357S plas-
mids, using Lipofectamine 3000 reagent (Invitrogen) according to
manufacturer’s instructions. Cells were then harvested 24 h later
and pellets frozen until at –80 C until required.
Biotin pull-down assay
Biotin pull-downs (25) from Drosophila heads were per-
formed as previously described (26). In brief, about 500 mg of
heads of control and ari-1OE flies was homogenized in 2.9 ml
of lysis buffer. Lysates were centrifuged at 16,000g at 4 C for
5 min and the supernatant applied to a binding buffer-equili-
brated PD10 desalting column (GE Healthcare). Eluates,
except 50 μl kept as input fraction, were incubated with 250 μl
of NeutrAvidin agarose resin (Thermo Scientific) for 40 min at12 J. Biol. Chem. (2021) 296 100408room temperature and further 2 h and 20 min at 4 C with
gentle rolling. The material bound to the resin was washed
twice with washing buffer (WB) 1, thrice with WB2, once with
WB3, thrice with WB4, once again with WB1, once with WB5,
and thrice with WB6. The material that was still bound to the
resin (i.e., the ubiquitinated material) was eluted by heating the
resin at 95 C for 5 min in 125 μl of elution buffer. Finally,
samples were centrifuged at 16,000g at room temperature for
2 min in a Vivaclear Mini 0.8 μm PES-micro-centrifuge filter
unit (Sartorious) to discard the NeutrAvidin resin.
Buffer compositions for the biotin pulldown assays were as
follows: lysis buffer, 8 M urea, 1% SDS, 1× PBS, 50 mM N-
ethylmaleimide (Sigma), and a protease inhibitor cocktail
(Roche); biding buffer, 3 M urea, 1 M NaCl, 0.25% SDS, 1× PBS
and 50 mM N-ethylmaleimide; WB1, 8 M urea, 0.25 SDS, 1×
PBS; WB2, 6 M guanidine-HCl, 1× PBS; WB3, 6.4 M urea, 1 M
NaCl, 0.2% SDS, 1× PBS; WB4, 4 M urea, 1 M NaCl, 10%
isopropanol, 10% ethanol, 0.2% SDS, 1× PBS; WB5, 8 M urea,
1% SDS, 1× PBS; WB6, 2% SDS, 1× PBS; elution buffer,
250 mM Tris-HCl, pH 7.5, 40% glycerol, 4% SDS, 0.2% bro-
mophenol blue, and 100 mM dithiothreitol (DTT).
GFP pull-down assay
GFP pull-downs from HEK293T cells were performed as
previously described (30, 31). In the case of fly samples, slight
modifications were added to adapt the protocol to Drosophila
heads. Briefly, about 100 mg of mixed-sex fly heads of comt and
ari-1OE/comt flies was homogenized in 400 μl of lysis buffer.
Lysates were centrifuged once at 16,000g at room temperature
for 1 min, in order to get rid of most of the Drosophila head
fragments, and then centrifuged once again at 16,000g at 4 C for
10 min. In total, 40 μl of the supernatants was kept as input,
while 300 μl was diluted with 450 μl of dilution buffer to reduce
their Triton concentration to 0.2% for a better binding. Diluted
samples (750 μl) were then incubated with 40 μl of dilution
buffer-washed GFP-Trap-A agarose beads suspension (Chro-
motek GmbH) for 2 h and 30 min at room temperature with
gentle rolling. GFP beads were subsequently washed once with
dilution buffer, thrice with washing buffer, and once with SDS
buffer. Bound GFP-tagged Comt was eluted in 50 μl of elution
buffer by heating at 95 C for 10 min. Samples were centrifuged
at 16,000g for 2 min and supernatant recovered, in order to get
rid of the GFP-Trap-A agarose beads.
Buffer compositions for the GFP pull-down assays were as
follows: lysis buffer, 50 mM Tris-HCl, pH 7.5, 150 mM NaCl,
1 mM EDTA, 0.5% Triton, 50 mM N-ethylmaleimide (Sigma),
and 1× protease inhibitor cocktail (Roche); dilution buffer,
10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 50 mM
N-ethylmaleimide, and 1× protease inhibitor cocktail; washing
buffer, 8 M urea, 1% SDS, 1× PBS; elution buffer, 250 mM Tris-
HCl, pH 7.5, 40% glycerol, 4% SDS, 0.2% bromophenol blue,
and 100 mM DTT.
In-gel trypsin digestion and peptide extraction
Eluates from biotin pull-down assays were concentrated in
Vivaspin 500 centrifugal filter units (Sartorius) and resolved by
Ubiquitinated synaptic NSFSDS-PAGE in 4–12% Bolt Bis-Tris precast gels (Invitrogen).
Proteins were visualized with GelCode blue stain reagent
(Invitrogen) and avidin monomers (15 kDa) and dimers
(30 kDa), still present in the samples, as well as an endoge-
nously biotinylated protein found at 130 kDa were excluded.
For that, the gels were cut into the following slices: slice A1
from 15 kDa to 25 kDa; slice A2 from 30 kDa to 50 kDa;
slice B from 50 kDa to 130 kDa, and slice C from 140 kDa
to up to the gel. These four slices were then subjected to in-gel
trypsin digestion as described previously (69). In brief, proteins
were first reduced with DTT and then alkylated with chlor-
oacetamide. Afterward, gel pieces were saturated with trypsin
and incubated overnight at 37 C. The resulting peptides were
extracted from the gel, dried down in a vacuum centrifuge, and
stored at –20 C. Peptide mixtures were resuspended in 0.1%
formic acid for LC-MS/MS analysis.
LC-MS/MS analysis
An EASY-nLC 1000 liquid chromatography system interfaced
with a Q Exactive mass spectrometer (Thermo Scientific) via a
nanospray flex ion source was employed for the mass spectro-
metric analyses. Peptides were loaded onto an Acclaim Pep-
Map100 pre-column (75 μm × 2 cm, Thermo Scientific)
connected to an Acclaim PepMap RSLC (50 μm × 15 cm,
Thermo Scientific) analytical column. A 2 to 40% acetonitrile in
0.1% formic acid linear gradient, at a flow rate of 300 nl min−1
over 45 min, was used to elute peptides from the columns. The
mass spectrometer was operated in positive ion mode. Full MS
scans were acquired from m/z 300 to 1850 with a resolution of
70,000 atm/z 200. The tenmost intense ions were fragmented by
higher energy C-trap dissociation with normalized collision en-
ergy of 28. MS/MS spectra were recorded with a resolution of
17,500 atm/z 200. The maximum ion injection time was 120 ms
for both survey and MS/MS scans, whereas automatic gain
control target values of 3 × 106 and 5 × 105 were used for survey
and MS/MS scans, respectively. Dynamic exclusion was applied
for 45 s to avoid repeated sequencing of peptides. Singly charged
ions or ions with unassigned charge state were also excluded
from MS/MS. Data were acquired using Xcalibur software
(Thermo Scientific).
Data processing and bioinformatics analysis
Acquired raw data files were processed with the MaxQuant
(70) software (version 1.5.3.17) using the internal search engine
Andromeda (71) and tested against the UniProt database
filtered for Drosophila melanogaster entries (release 2015_11;
43,712 entries). Spectra originated from the different slices
corresponding to the same biological sample were combined.
Carbamidomethylation (C) was set as a fixed modification,
whereas methionine oxidation, protein N-terminal acetylation,
and lysine GlyGly (not C-term) were defined as variable modi-
fications. Mass tolerance was set to 8 and 20 ppm at the MS and
MS/MS level, respectively. Enzyme specificity was set to trypsin,
allowing for a maximum of three missed cleavages. Match be-
tween runs optionwas enabledwith 1.5minmatch timewindow
and 20 min alignment window to match identification acrosssamples. The minimum peptide length was set to seven amino
acids. The false discovery rate for peptides and proteins was set
to 1%. Normalized spectral protein LFQ intensities were
calculated using the MaxLFQ algorithm (33).
Western blot analysis
In total, 4–12% gradient Bolt Bis-Tris Plus precast gels
(Invitrogen) were used for SDS-PAGE. Proteins were trans-
ferred to PVDF membranes using the iBlot system (Invi-
trogen). Following blocking, primary and secondary antibody
incubation, membranes were developed either by chem-
iluminescence, using the Clarity Western ECL Substrate kit
(Bio-Rad), or by near-infrared fluorescence. In both cases
membranes were developed using the ChemiDoc MP Imaging
system (Bio-Rad). Biotinylated proteins and, thus, ubiquiti-
nated proteins were detected with goat anti-biotin horseradish
peroxidase (HRP)-conjugated antibody (Cell Signaling Tech-
nology, Cat# 7075) at 1:1000. A mouse monoclonal anti-BirA
antibody (Novus Biologicals, Cat# NBP2-59939) at 1:500 was
used to detect BirA protein. A mouse monoclonal anti-GFP
antibody (Roche, Cat# 11814460001) at 1:1000, as well as a
rabbit polyclonal anti-GFP antibody (Santa Cruz Biotech-
nology, Cat# sc-8334) at 1:1000, was used to detect fly Comt-
GFP and human GFP-NSF proteins. A mouse monoclonal
anti-FLAG M2 HRP-conjugated antibody (Sigma; Cat# A8592)
at 1:1000 was used to detect FLAG-tagged ubiquitin, as well as
wild-type and catalytically inactive FLAG-tagged ARIH1. A
mouse monoclonal anti-β-Tubulin (Developmental Studies
Hybridoma Bank, Cat# E7-c) at 1:1000 was used for loading
control. Goat anti-rabbit HRP-labeled antibody (Cell Signal-
ling, Cat# 7074) at 1:4000 and goat anti-mouse IRDye-800CW
(LI-COR Biosciences, Cat# 926-32210) at 1:8000 were used as
secondary antibodies.
Larval neuromuscular preparation
Mature third instar larvae at the wandering stage were
selected for electrophysiological recordings. As previously
described (72), they were pinned down onto a Sylgard-coated
experimental chamber and cut open along the dorsal midline
in an extracellular solution containing 100 mM NaCl, 5 mM
KCl, 20 mM MgCl2, 5 mM HEPES, and 115 mM Sucrose (pH
7.3). After pinning the cuticle flat, all internal organs were
removed to expose the body-wall muscle layer, leaving only the
central nervous system connected to the muscles through the
segmental nerves. These were severed near the CNS and their
cut-open ends sucked into a fired-polished glass suction
pipette filled with extracellular saline solution. The prepara-
tions were then transferred to the microscope for electro-
physiological recordings and viewed with a 40× water
immersion objective under Nomarski optics. All experiments
were performed at room temperature (21–23 C) on ventro-
lateral muscle fibers from segments A2–A5.
Electrophysiology
Spontaneous (mEJCs) and nerve-evoked (EJCs) junctional
currents were recorded from muscle fibers 6 and 12, using anJ. Biol. Chem. (2021) 296 100408 13
Ubiquitinated synaptic NSFAxoclamp-2A amplifier in two-electrode voltage-clamp
(TEVC) mode. Short-shank pipettes (8–10 MΩ resistance
when filled with 1 M KCl solution) were pulled on a Flaming-
Brown puller (Sutter Instruments) from thin-wall borosilicate
glass (World Precision Instruments). Upon establishing TEVC,
the feedback gain control of the amplifier was adjusted, while
monitoring the current response to repetitive hyperpolarizing
voltage commands, as to obtain a minimal clamp settling time
(2 ms) without introducing oscillations or excess noise in the
current trace. The holding current, always less than −5 nA for
a holding potential of –80 mV, was continuously monitored
throughout the experiment. Current signals were low-pass
filtered at 500–1000 Hz, digitized, and stored in a computer
for further off-line analysis using a computer program (SNAP)
written in our lab. Current signals were recorded in extracel-
lular solution to which calcium had been added as a chloride
salt to attain the desired final concentration (0–1.2 mM) as
indicated in the text. The number of mEJCs acquired in free-
run mode over 3-min periods was counted in order to deter-
mine the average frequency of spontaneous release. To
compare the mEJCs amplitude distribution between geno-
types, data recorded from different animals (200 consecutive
events from each animal) of the same genotype were pooled
into single data sets.
Evoked EJCs were elicited in voltage-clamped muscle fibers
by delivering single pulses (100–200 μs) from a stimulator
(Cibertec Stimulator CS 20). The stimulus intensity was
adjusted slightly over the level required to recruit both motor
axons innervating ventrolateral muscle fibers to produce a
compound EJC. A mean EJC response for each muscle fiber
sampled was obtained by averaging 25 to 50 consecutive re-
sponses elicited at 0.2 Hz. Extracellular focal synaptic signals
from single boutons were recorded by placing extracellular pi-
pettes (fired polished, 2–5 μm inner diameter) over type Is
boutons, easily identified under Nomarski optics, and applying
very gentle suction, which was released prior to the beginning of
the experiment. Only those boutons showing no visible signs of
damage after the experiment were considered in the analysis. In
those experiments designed to assess single-terminal failure
rates, whole-muscle EJPs were simultaneously recorded with
intracellular electrodes in current-clamp mode, as to detect any
possible stimulation failure susceptible of being wrongly classed
as a release failure. Pooled data in the text are presented as
mean ± SEM. The Student’s t test with a level of significance p<
0.05 was routinely used to compare mean values between
different genotypes, except when comparing mEJC amplitude
distributions, where a Kolmogorov–Smirnov test was used.Immunohistochemical procedures
Third instar larvae were dissected open as described and
then fixed for 30 min in freshly made 4% paraformaldehyde in
Ca2+-free PBS containing 5 mM EGTA. After a series of
washes with PBS, the larvae were incubated in PBT (0.1%
Triton in PBS) with 2% BSA and 5% goat serum, added for 2 h
at room temperature. Specimens were next incubated in
mouse monoclonal anti-CSP antibody (mAb49) at 1:100 (73,14 J. Biol. Chem. (2021) 296 10040874), overnight at 4 C in PBT, thoroughly washed in PBT, and
then incubated in secondary anti-mouse antibody (1:1000)
conjugated to Cy2 (Jackson Immuno Research, cat# 115-225-
146), for 1 h at room temperature. Preparations were mounted
on PBS:glycerol (1:1) and viewed under confocal microscopy.
Temperature-sensitive paralysis and recovery
Adult females aged 3–7 days were tested individually in vials
on a 37 C water bath. The criterion for paralysis was the fly’s
cessation of movement in all appendages and loss of standing
position. The criterion for recovery was the ability to stand up
on the six legs. Flies were anesthetized under CO2, allowed to
recover for 1 h, and monitored visually while the vial was in the
bath. Once paralyzed, the vial was kept in the 37 C bath for
1 min before being taken out to room temperature to measure
fly’s recovery time. Cultures and crosses were raised at room
temperature.
Experimental design and statistical analyses
Biotin pull-downs
Experiments were performed in triplicate, where 500 mg of
mixed-sex fly heads of each genotype (control and ari-1OE) for
each replica was used. The amount of heads was set to 500mg to
maximize the amount of ubiquitinated material that is purified
and to minimize the amount of reagents that are used. This
amount of heads ensures the isolation of enough ubiquitinated
material for MS analyses, but does not saturate the PD10 col-
umns, so only one per sample is used. Additionally, the amount
of NeutrAvidin beads used can be reduced significantly. After
MS analysis, MaxQuant output data from control and ari-1OE
samples were analyzedwith the Perseusmodule (version 1.5.6.0)
(75) in order to determine the proteins and GlyGly peptides
significantly enriched in each of the genotypes. First, contami-
nants, reverse hits, as well as proteins and GlyGly peptides with
no intensity were removed. Later, during the analysis of pro-
teins, those only identified by site and/or with no unique pep-
tides were also removed. LFQ intensities were used to determine
the abundance of proteins, while raw intensities, normalized by
median subtraction, were used for GlyGly peptides. Missing
intensity values were replaced with values from a normal dis-
tribution (width 0.3 and down shift 1.8), meant to simulate
expression below the detection limit (75). Statistically signifi-
cant changes in protein and GlyGly peptide abundance were
assessed by two-tailed Student’s t test. Proteins and GlyGly
peptides displaying a fold change above 2 with a p-value below
0.05were selected for further analysis. The selected proteins and
peptides were further filtered based on the number of unique
peptides and/or on the number of imputed values. For further
analyses, we only considered the statistical significance of those
proteins that (i) had no imputed values in any of the three
replicas of at least one of the conditions or (ii) had amaximumof
one imputed value in each of the conditions.
GFP pull-downs
Experiments were performed in triplicate, where 100 mg of
mixed-sex fly heads of each genotype (comt and ari-1OE/comt)
Ubiquitinated synaptic NSFfor each replica was used. The amount of heads was deter-
mined as the minimum amount needed to saturate 40 μl of
GFP-Trap_A beads. Experiments were also performed in
triplicate from cell samples, for which 25 μl of GFP-Trap_A
beads were used per replica as previously described (31).
Semiquantification of dual-color western blots was performed
with Image Lab software (Bio-Rad). Ubiquitination levels of
GFP-tagged Comt and GFP-NSF were normalized to the
nonmodified fractions. Statistical significance of the ubiquiti-
nation levels was then determined by two-tailed Student’s t
test using GraphPad software.
Electrophysiology statistical analysis
All statistical analyses were done by the GraphPad Prism
version 7.0 (GraphPad Software). Data are presented as
mean ± SEM unless otherwise noted. Two-tailed Student’s t
test was used to assess differences between control and other
groups. One-way ANOVA was used for analysis of data from
three or more groups followed by two-tailed Student’s t test,
coefficients of significance are included in the figures.
Data availability
Original mass spectrophotometry data are deposited in the
PRIDE repository under accession number PXD022701. All
other original data are available in the main text and figures.
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